Acetyl-Histone H4 (Lys12) Antibody

What is the biological significance of H4K12 acetylation in chromatin regulation?

Acetylation of histone H4 at lysine 12 (H4K12ac) reflects the hyperacetylated state in histone H4 and is strongly correlated with active states of genes. This modification plays a critical role in the regulation of chromatin structure and recruitment of transcription factors to gene promoters. H4K12 acetylation is governed by the balance between histone acetyltransferases (HATs) and histone deacetylases (HDACs), with increased acetylation observed following HDAC inhibition and decreased acetylation following HAT inhibition .

Research has shown that H4K12ac is involved in cancer and inflammatory diseases, making it an important epigenetic marker for both basic research and translational medicine applications . Studies have also demonstrated that H4K12ac is regulated by estrogen receptor-alpha and is associated with BRD4 function and inducible transcription, suggesting its role in hormone-responsive gene regulation .

What applications are supported by Acetyl-Histone H4 (Lys12) antibodies?

Acetyl-Histone H4 (Lys12) antibodies have been validated for multiple research applications:

These applications enable researchers to investigate H4K12ac in various experimental contexts, from analyzing protein levels to mapping genome-wide distribution patterns .

What species reactivity should be expected with commercial H4K12ac antibodies?

Most commercial anti-acetyl-histone H4 (Lys12) antibodies demonstrate broad species reactivity due to the high conservation of histone proteins across species. Based on the available sources, researchers can expect reactivity with:

• Human

• Mouse

• Rat

• Monkey (including Macaque)

• Yeast (particularly Saccharomyces cerevisiae)

When selecting an antibody for your experiment, verify the specific species reactivity in the product documentation. Some antibodies have been specifically validated for certain species while others are predicted to work based on sequence homology .

How should I optimize my ChIP protocol when using Acetyl-Histone H4 (Lys12) antibodies?

For optimal ChIP results using Acetyl-Histone H4 (Lys12) antibodies, follow these methodological guidelines:

• Antibody amount: Use 10 μl of antibody and 10 μg of chromatin (approximately 4 × 10^6 cells) per immunoprecipitation .

• Positive control regions: For qPCR validation, use established positive control primers for active gene regions. For human samples, ACTB-2 primers are recommended, and for mouse samples, Actb-2 primers have been validated .

• Negative control regions: Include genomic regions known to lack H4K12ac to establish background levels. Validated negative control primer sets are available for both human and mouse samples .

• Cross-validation: Multiple studies have used H4K12ac antibodies in ChIP-seq applications, including the modENCODE and NIH Roadmap Epigenomics Mapping Consortiums, which have implemented rigorous standardization criteria. Use their published protocols as a starting point .

• Chromatin preparation: Enzymatic digestion methods work well for histone modifications, but ensure optimal digestion conditions to generate 150-300 bp fragments for high-resolution mapping.

Research has demonstrated successful application of these antibodies in identifying the relationship between H4K12ac and transcription factors, particularly in estrogenic signaling pathways and during DNA replication .

What controls should I include when validating a new Acetyl-Histone H4 (Lys12) antibody lot?

Proper validation of Acetyl-Histone H4 (Lys12) antibodies is essential for experimental reproducibility. Include these controls:

• Positive cellular controls: Use HeLa cells treated with HDAC inhibitors such as sodium butyrate or trichostatin A, which increase global H4K12 acetylation levels. These treated cells serve as excellent positive controls for Western blot and immunofluorescence applications .

• Peptide competition assays: Perform dot blot analysis using both acetylated and non-acetylated peptides to confirm specificity for the acetylated form of H4K12 .

• Cross-reactivity testing: Test against other acetylated lysine residues on histone H4 (e.g., H4K5ac, H4K8ac, H4K16ac) to ensure specificity for the K12 position.

• Cell line validation: Several cell lines have been validated for H4K12ac detection, including:

  • HeLa cells

  • NIH/3T3 cells

  • HEK-293 cells

  • HSC-T6 cells

  • Caco-2 cells

• Tissue validation: Mouse small intestine tissue has been validated for IHC applications using Acetyl-Histone H4 (Lys12) antibodies .

For extended validation, consider comparing results from different antibody clones or manufacturers, as this can provide additional confidence in experimental findings .

How can I quantify global levels of H4K12 acetylation in different experimental conditions?

For accurate quantification of global H4K12 acetylation levels, several complementary approaches are recommended:

• Fluorometric quantification kits: Specialized kits like the EpiSeeker Histone H4 (acetyl K12) Quantification Kit provide a standardized method for measuring global H4K12ac levels. These kits typically use an antibody capture system where acetyl histone H4-K12 is captured in strip wells coated with an anti-acetyl H4-K12 antibody and then detected with a labeled detection antibody, followed by fluorescent development .

• Western blot quantification: For relative quantification between samples:

  • Use equal loading of acid-extracted histones (typically 10-15 μg)

  • Normalize signal to total H4 or another stable protein marker

  • Process all samples simultaneously to minimize technical variation

  • Use appropriate image analysis software for densitometry

• Flow cytometry: For single-cell level quantification:

  • Fix and permeabilize cells thoroughly

  • Use a 1:1600 dilution of the antibody

  • Include unstained and isotype controls

  • Quantify mean fluorescence intensity across populations

• ChIP-seq followed by computational analysis: For genome-wide assessment:

  • Calculate the total number of H4K12ac peaks

  • Measure the average peak intensity or area under the curve

  • Compare these metrics across conditions

These methods have been successfully applied in studies examining H4K12ac changes during development, in disease states, and in response to drug treatments .

How do I interpret contradictory data when comparing different Acetyl-Histone H4 (Lys12) antibody sources?

When faced with contradictory results from different H4K12ac antibodies, follow this systematic approach to resolve discrepancies:

• Review antibody characteristics:

  • Compare polyclonal versus monoclonal antibodies (polyclonals may recognize multiple epitopes while monoclonals provide higher specificity)

  • Examine immunogen design (the exact sequence used to generate the antibody)

  • Check production methods (recombinant antibodies typically offer superior lot-to-lot consistency)

• Evaluate validation evidence:

  • Compare validation methods across antibodies (ChIP-seq, Western blot, peptide competition)

  • Check for peer-reviewed publications that have used these specific antibodies

  • Review consortium data (modENCODE, NIH Roadmap) for standardized comparisons

• Perform head-to-head validation:

  • Run parallel ChIP-qPCR on known positive and negative regions

  • Compare Western blot patterns using the same sample preparation

  • Validate with orthogonal techniques (e.g., mass spectrometry)

• Technical considerations:

  • Different fixation methods can affect epitope accessibility

  • Buffer conditions can influence antibody performance

  • Batch effects in ChIP-seq must be controlled for

Multiple studies have successfully used different antibody sources after careful validation, as evidenced by publications examining H4K12ac in postmeiotic sperm development, transcription regulation, and chromatin dynamics during DNA replication .

How does H4K12 acetylation interact with other histone modifications in the histone code?

H4K12 acetylation functions within a complex network of histone modifications that collectively regulate chromatin structure and gene expression. Understanding these interactions is crucial for comprehensive epigenetic analysis:

• Co-occurring modifications:

  • H4K12ac frequently co-occurs with other acetylation marks on histone H4 (H4K5ac, H4K8ac, H4K16ac) in active chromatin regions

  • Research has shown relationships between H4K12ac and H3K9 methylation, with one study demonstrating that methylation of histone H3 lysine 9 occurs during translation

• Functional relationships:

  • H4K12ac serves as a docking site for bromodomain-containing proteins, particularly BRD4, which has been shown to associate with H4K12ac during mammalian postmeiotic sperm development

  • The relationship between H4K12ac and BRD4 is particularly important in estrogen receptor-alpha regulated transcription

• Genome-wide distribution patterns:

  • Epigenomic mapping has revealed complex patterns of H4K12ac variation between natural yeast strains at single-nucleosome resolution

  • These patterns correlate with specific gene expression programs and regulatory functions

• Temporal dynamics:

  • During DNA replication, nascent chromatin capture proteomics has determined chromatin dynamics including changes in H4K12ac levels

  • Studies have revealed components of replication forks that interact with H4K12ac

Research has also demonstrated that acute histone acetylation, including H4K12ac, plays a crucial role in modulating inducible gene transcription, as shown in studies of the Ifng locus . These findings highlight the importance of examining H4K12ac within the broader context of the histone code.

What are common troubleshooting steps for weak or non-specific signals when using H4K12ac antibodies?

When encountering weak or non-specific signals with H4K12ac antibodies, implement these targeted troubleshooting measures:

• For weak Western blot signals:

  • Increase antibody concentration (try 1:1000 instead of 1:5000)

  • Optimize extraction methods (use acid extraction for histones)

  • Enhance blocking (5% BSA may be more effective than milk for phospho-epitopes)

  • Increase exposure time or use more sensitive detection methods

  • Consider using HDAC inhibitors (sodium butyrate or trichostatin A) to increase acetylation levels in positive controls

• For high background in immunofluorescence:

  • Increase dilution (1:600 to 1:2000 range)

  • Optimize fixation (4% paraformaldehyde for 10-15 minutes)

  • Improve permeabilization (0.1-0.5% Triton X-100)

  • Extend blocking time (1-2 hours at room temperature)

  • Include additional washing steps

• For ChIP-seq issues:

  • Verify chromatin fragmentation (aim for 150-300 bp fragments)

  • Adjust antibody-to-chromatin ratio (10 μl antibody to 10 μg chromatin is recommended)

  • Include appropriate controls (IgG negative control, input normalization)

  • Optimize cross-linking conditions (1% formaldehyde for 10 minutes at room temperature)

• For all applications:

  • Verify antibody storage conditions (aliquot and store at -20°C)

  • Check antibody lot variation (refer to certificates of analysis)

  • Confirm target protein expression in your experimental system

  • Test with validated positive controls (HeLa cells treated with HDAC inhibitors)

These approaches have been substantiated by multiple research groups successfully using H4K12ac antibodies in diverse experimental contexts .

How do different sample preparation methods affect H4K12ac antibody performance?

Sample preparation significantly impacts H4K12ac antibody performance across different applications. Optimize preparation methods based on these evidence-based guidelines:

• For Western blotting:

  • Extraction method: Acid extraction (0.2N HCl or 0.4N H₂SO₄) is preferred for histones

  • Sample buffer: Add 0.1-0.2% SDS to help denature the sample completely

  • Loading amount: 10-15 μg of acid-extracted histones is typically sufficient

  • Transfer conditions: Use PVDF membranes and carefully optimize transfer time/voltage for small proteins (11 kDa)

• For immunofluorescence/immunohistochemistry:

  • Fixation: 4% paraformaldehyde for 10-15 minutes at room temperature

  • Antigen retrieval for tissues: Use TE buffer pH 9.0 or citrate buffer pH 6.0

  • Permeabilization: 0.1-0.5% Triton X-100 for 5-10 minutes

  • Buffer systems: PBS-based buffers work well for most applications

• For ChIP and ChIP-seq:

  • Cross-linking: 1% formaldehyde for 10 minutes at room temperature

  • Sonication vs. enzymatic digestion: Both work, but enzymatic methods may better preserve epitopes

  • Chromatin amount: 10 μg of chromatin (approximately 4 × 10^6 cells) per IP

  • Wash stringency: Balance between reducing background and maintaining specific interactions

• For flow cytometry:

  • Fixation: 2-4% paraformaldehyde

  • Permeabilization: Methanol or saponin-based methods

  • Cell concentration: 1 × 10^6 cells/mL

  • Antibody dilution: 1:1600 recommended

Research has demonstrated that these preparation methods significantly influence experimental outcomes, with appropriate sample preparation being crucial for accurate detection of H4K12ac across experimental systems .

How do H4K12ac patterns change during cellular differentiation and development?

H4K12ac undergoes dynamic changes during differentiation and development, serving as a key epigenetic regulator of gene expression programs:

• During spermatogenesis and sperm development:

  • Research has characterized BRD4 association with H4K12ac during mammalian postmeiotic sperm development

  • These studies revealed stage-specific changes in H4K12ac patterns critical for proper sperm maturation

• In stem cell differentiation:

  • H4K12ac marks undergo redistribution during differentiation

  • These changes correlate with activation and repression of lineage-specific genes

  • The dynamics can be studied using ChIP-seq approaches validated with H4K12ac antibodies

• During embryonic development:

  • H4K12ac patterns are established early in development

  • The modification plays roles in establishing and maintaining developmental gene expression programs

  • Various studies have used H4K12ac antibodies to map these changes throughout development

• In chromatin remodeling during DNA replication:

  • Nascent chromatin capture proteomics has determined chromatin dynamics during DNA replication

  • H4K12ac is involved in the recruitment of specific protein complexes during this process

  • These studies have identified previously unknown fork components associated with H4K12ac

Understanding these developmental changes in H4K12ac has significant implications for research in developmental biology, reproductive biology, and regenerative medicine .

What is the relationship between H4K12ac and disease states, particularly in cancer?

H4K12ac alterations have been implicated in various pathological conditions, with particularly strong connections to cancer development and progression:

• Cancer associations:

  • H4K12ac is regulated by estrogen receptor-alpha and is associated with BRD4 function and inducible transcription, with direct implications for hormone-responsive cancers

  • Research has demonstrated that lunasin sensitivity in non-small cell lung cancer cells is linked to suppression of integrin signaling and changes in histone acetylation, including H4K12ac

  • Altered H4K12ac patterns have been observed across multiple cancer types, suggesting its potential use as a biomarker

• Inflammatory conditions:

  • H4K12ac is involved in inflammatory gene regulation

  • Studies have shown its role in modulating inducible gene transcription, particularly in immune response genes

  • Deletion of conserved cis-elements in the Ifng locus has highlighted the role of acute histone acetylation, including H4K12ac, in regulating inflammatory responses

• Therapeutic implications:

  • HDAC inhibitors, which increase H4K12ac levels, are being investigated as cancer therapeutics

  • BRD4 inhibitors, which target proteins that bind to acetylated histones including H4K12ac, show promise in cancer treatment

  • Understanding H4K12ac patterns may help identify patients likely to respond to epigenetic therapies

• Diagnostic potential:

  • H4K12ac patterns may serve as diagnostic or prognostic markers

  • Antibodies against H4K12ac can be used in immunohistochemistry to assess acetylation levels in patient samples

  • These applications require highly specific antibodies validated for clinical research applications

Research continues to explore these connections, with H4K12ac antibodies serving as essential tools for investigating epigenetic dysregulation in disease contexts .

How can I design experiments to investigate the relationship between H4K12ac and transcriptional regulation?

To effectively investigate the relationship between H4K12ac and transcriptional regulation, implement these experimental design strategies:

• Integrated ChIP-seq and transcriptome analysis:

  • Perform ChIP-seq using validated H4K12ac antibodies (10 μl per IP with 10 μg chromatin)

  • Conduct RNA-seq or microarray analysis on the same samples

  • Correlate H4K12ac peaks with gene expression levels

  • Look for enrichment patterns around transcription start sites, enhancers, and gene bodies

  • This approach has successfully revealed correlations between H4K12ac and active transcription in multiple studies

• Perturbation experiments:

  • Modulate H4K12ac levels using HDAC inhibitors (sodium butyrate, trichostatin A) or HAT inhibitors

  • Track changes in both H4K12ac levels (by ChIP-qPCR or Western blot) and gene expression (by RT-qPCR)

  • Focus on specific loci of interest based on preliminary data

  • Include time course experiments to capture dynamic changes

• Protein interaction studies:

  • Identify proteins that bind to H4K12ac using techniques like pulldown assays with acetylated peptides

  • Perform co-immunoprecipitation with H4K12ac antibodies to identify associated proteins

  • Validate interactions using reciprocal IPs and Western blotting

  • Studies have used these approaches to demonstrate associations between H4K12ac and transcriptional regulators like BRD4

• Mechanistic investigations:

  • Employ CRISPR-based epigenome editing to alter H4K12ac at specific loci

  • Use reporter assays to assess the functional impact of H4K12ac on promoter activity

  • Combine with ChIP for other histone marks to understand the broader epigenetic context

  • These approaches help establish causality rather than mere correlation

Research has demonstrated that H4K12ac is regulated by estrogen receptor-alpha and associated with BRD4 function in inducible transcription, providing a framework for investigating hormone-responsive gene regulation . Additionally, studies have examined the role of H4K12ac in specific contexts like the Ifng locus, highlighting its importance in acute transcriptional responses .